Literature DB >> 22452861

Clinical characteristics, process of care and outcomes among Mexican, Hispanic and non-Hispanic white patients presenting with non-ST elevation acute coronary syndromes: data from RENASICA and CRUSADE registries.

Carlos Jerjes Sánchez-Diaz1, Edgar García-Badillo, Carlos Jerjes Sánchez-Ramírez, Úrsulo Juárez, Carlos Martínez-Sánchez.   

Abstract

INTRODUCTION: Data regarding management characteristics of non-ST elevation acute coronary syndromes (NSTE ACS) in Mexican, Hispanic and Non- Hispanic white patients are scarce.
METHODS: We sought to describe the clinical characteristics, process of care, and outcomes of Mexicans, Hispanics and non-Hispanic whites presenting with NSTE ACS at Mexican and US hospitals. We compared baseline characteristics, resource use, clinical practice guidelines (CPGs) compliance and in-hospital mortality among 3 453 Mexicans, 3 936 Hispanics and 90, 280 non-Hispanic whites with NSTE ACS from the RENASICA and CRUSADE registries.
RESULTS: Mexicans were younger with a different cardiovascular risk profile, fewer incidences of hypertension (p<0.001), hyperlipidemia (p<0.001), renal failure (p<0.001) and prior revascularization (p<0.001) but were more likely to be smoking compared with Hispanics and non-Hispanic white populations. Mexicans and Hispanics had a higher incidence of diabetes (p<0.001). At clinical presentation Mexican patients were more likely to have ST depression (p<0.001) but less likely to have left ventricular dysfunction (p<0.001) and troponin stratification (p<0.001). Regarding CPGs compliance, aspirin was used in 90% of patients in all groups, but clopidogrel or unfractionated or low-molecular weight heparin in 50% of patients or less. Mexican patients were less likely to receive glycoprotein IIb/IIIa inhibitors and revascularization. In spite of clinical differences and therapeutic trends, cardiovascular mortality was similar among all groups (Mexicans 4%, Hispanics 4% and non-Hispanic white 5%). In all groups of patients, a poor CPGs compliance was observed.
CONCLUSIONS: In a post-hoc analysis, Mexican patients with NSTE ACS had a different cardiovascular risk factor profile and clinical presentation, and less intensive in - hospital treatment than Hispanic and non-Hispanic white patients. However, these differences do not appear to affect in - hospital mortality.

Entities:  

Mesh:

Year:  2012        PMID: 22452861

Source DB:  PubMed          Journal:  Arch Cardiol Mex        ISSN: 1665-1731


  2 in total

Review 1.  Population-level differences in revascularization treatment and outcomes among various United States subpopulations.

Authors:  Garth Graham; Yang-Yu Karen Xiao; Dan Rappoport; Saima Siddiqi
Journal:  World J Cardiol       Date:  2016-01-26

2.  Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease.

Authors:  Rashidi Springall; Luis M Amezcua-Guerra; Hector Gonzalez-Pacheco; Janette Furuzawa-Carballeda; Lorena Gomez-Garcia; Ricardo Marquez-Velasco; Ana María Mejía-Domínguez; Jorge Cossío-Aranda; Carlos Martínez-Sánchez; Rafael Bojalil
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.